150 related articles for article (PubMed ID: 31728974)
1. SMaRT for Therapeutic Purposes.
Riedmayr LM
Methods Mol Biol; 2020; 2079():219-232. PubMed ID: 31728974
[TBL] [Abstract][Full Text] [Related]
2. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
[TBL] [Abstract][Full Text] [Related]
3. Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.
Philippi S; Lorain S; Beley C; Peccate C; Précigout G; Spuler S; Garcia L
Hum Mol Genet; 2015 Jul; 24(14):4049-60. PubMed ID: 25904108
[TBL] [Abstract][Full Text] [Related]
4. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
5. RNA trans-splicing for genodermatoses.
Bauer JW; Murauer EM; Wally V; Koller U
Methods Mol Biol; 2013; 961():441-55. PubMed ID: 23325663
[TBL] [Abstract][Full Text] [Related]
6. mRNA trans-splicing in gene therapy for genetic diseases.
Berger A; Maire S; Gaillard MC; Sahel JA; Hantraye P; Bemelmans AP
Wiley Interdiscip Rev RNA; 2016 Jul; 7(4):487-98. PubMed ID: 27018401
[TBL] [Abstract][Full Text] [Related]
7. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
[TBL] [Abstract][Full Text] [Related]
8. Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases.
Dallinger G; Puttaraju M; Mitchell LG; Yancey KB; Yee C; Klausegger A; Hintner H; Bauer JW
Exp Dermatol; 2003 Feb; 12(1):37-46. PubMed ID: 12631245
[TBL] [Abstract][Full Text] [Related]
9. A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosome-mediated RNA trans-splicing.
Walls ZF; Puttaraju M; Temple GF; Gambhir SS
J Nucl Med; 2008 Jul; 49(7):1146-54. PubMed ID: 18552150
[TBL] [Abstract][Full Text] [Related]
10. Spliceosome-mediated trans-splicing: the therapeutic cut and paste.
Wally V; Murauer EM; Bauer JW
J Invest Dermatol; 2012 Aug; 132(8):1959-66. PubMed ID: 22495179
[TBL] [Abstract][Full Text] [Related]
11. Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing.
Pergolizzi RG; Crystal RG
C R Biol; 2004 Aug; 327(8):695-709. PubMed ID: 15506518
[TBL] [Abstract][Full Text] [Related]
12. Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.
Rodriguez-Martin T; Anthony K; Garcia-Blanco MA; Mansfield SG; Anderton BH; Gallo JM
Hum Mol Genet; 2009 Sep; 18(17):3266-73. PubMed ID: 19498037
[TBL] [Abstract][Full Text] [Related]
13. Proximity-dependent and proximity-independent trans-splicing in mammalian cells.
Viles KD; Sullenger BA
RNA; 2008 Jun; 14(6):1081-94. PubMed ID: 18441053
[TBL] [Abstract][Full Text] [Related]
14. 5' exon replacement and repair by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Clark RH; Puttaraju M; Kole J; Cohn JA; Mitchell LG; Garcia-Blanco MA
RNA; 2003 Oct; 9(10):1290-7. PubMed ID: 13130143
[TBL] [Abstract][Full Text] [Related]
15. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun Y; Piñón Hofbauer J; Harada M; Wöss K; Koller U; Morio H; Stierschneider A; Kitamura K; Hashimoto M; Chiba K; Akita H; Anzai N; Reichelt J; Bauer JW; Guttmann-Gruber C; Furihata T
Cancer Lett; 2018 Oct; 433():107-116. PubMed ID: 29960051
[TBL] [Abstract][Full Text] [Related]
16. Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.
Wang J; Mansfield SG; Cote CA; Jiang PD; Weng K; Amar MJ; Brewer BH; Remaley AT; McGarrity GJ; Garcia-Blanco MA; Puttaraju M
Mol Ther; 2009 Feb; 17(2):343-51. PubMed ID: 19066600
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing.
Bhaumik S; Walls Z; Puttaraju M; Mitchell LG; Gambhir SS
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8693-8. PubMed ID: 15161977
[TBL] [Abstract][Full Text] [Related]
18. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
19. Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery.
Zayed H; Xia L; Yerich A; Yant SR; Kay MA; Puttaraju M; McGarrity GJ; Wiest DL; McIvor RS; Tolar J; Blazar BR
Mol Ther; 2007 Jul; 15(7):1273-9. PubMed ID: 17457319
[TBL] [Abstract][Full Text] [Related]
20. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?
Kikumori T; Cote GJ; Gagel RF
Hum Gene Ther; 2001 Jul; 12(11):1429-41. PubMed ID: 11485634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
